Abstract:Abstract Background Mithramycin is an anti-tumor compound of the aureolic acid family produced by Streptomyces argillaceus . Its biosynthesis gene cluster has been cloned and characterized, and several new analogs with improved pharmacological properties have been generated through combinatorial biosynthesis. To further study these compounds as potential new anticancer drugs requires their production yields to be improved significantly. The biosynthesis of mithramycin proceeds through the formation of the key intermediate 4-demethyl-premithramycinone. Extensive studies have characterized the biosynthesis pathway from this intermediate to mithramycin. However, the biosynthesis pathway for 4-demethyl-premithramycinone remains unclear. Results Expression of cosmid cosAR7, containing a set of mithramycin biosynthesis genes, in Streptomyces albus resulted in the production of 4-demethyl-premithramycinone, delimiting genes required for its biosynthesis. Inactivation of mtmL , encoding an ATP-dependent acyl-CoA ligase, led to the accumulation of the tricyclic intermediate 2-hydroxy-nogalonic acid, proving its essential role in the formation of the fourth ring of 4-demethyl-premithramycinone. Expression of different sets of mithramycin biosynthesis genes as cassettes in S. albus and analysis of the resulting metabolites, allowed the reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, assigning gene functions and establishing the order of biosynthetic steps. Conclusions We established the biosynthesis pathway for 4-demethyl-premithramycinone, and identified the minimal set of genes required for its assembly. We propose that the biosynthesis starts with the formation of a linear decaketide by the minimal polyketide synthase MtmPKS. Then, the cyclase/aromatase MtmQ catalyzes the cyclization of the first ring (C7–C12), followed by formation of the second and third rings (C5–C14; C3–C16) catalyzed by the cyclase MtmY. Formation of the fourth ring (C1–C18) requires MtmL and MtmX. Finally, further oxygenation and reduction is catalyzed by MtmOII and MtmTI/MtmTII respectively, to generate the final stable tetracyclic intermediate 4-demethyl-premithramycinone. Understanding the biosynthesis of this compound affords enhanced possibilities to generate new mithramycin analogs and improve their production titers for bioactivity investigation.

Formation of the Δ18,19 Double Bond and Bis(spiroacetal) in Salinomycin is Atypically Catalyzed by SlnM, a Methyltransferase‐like Enzyme

Aminoacyl sulfonamide assembly in SB-203208 biosynthesis.

SlnR is a Positive Pathway-Specific Regulator for Salinomycin Biosynthesis in Streptomyces Albus

Rifamycin Biosynthetic Congeners: Isolation and Total Synthesis of Rifsaliniketal and Total Synthesis of Salinisporamycin and Saliniketals A and B

Synthesis and biological activity evaluation of 20-epi-salinomycin and its 20-O-acyl derivatives

Design and synthesis of conformationally constrained salinomycin derivatives.

Structural basis of the stereoselective formation of the spirooxindole ring in the biosynthesis of citrinadins

Salinomycin biosynthesis reversely regulates the -oxidation pathway in <i>Streptomyces albus</i> by carrying a 3-hydroxyacyl-CoA dehydrogenase gene in its biosynthetic gene cluster

Identification of clerodane diterpene modifying cytochrome P450 (CYP728D26) in Salvia divinorum ‐ en route to psychotropic salvinorin A biosynthesis

Transcription Inhibition by the Depsipeptide Antibiotic Salinamide A

Salinopyridins A and B, Two Novel Polyethers with a Unique Pyridine Moiety from Streptomyces Sp. NA4227

Enzymatic reconstitution of salicylate formation in promysalin biosynthesis

Enzymatic assembly of the salinosporamide γ-lactam-β-lactone anticancer warhead

C-S Bond Cleavage By A Polyketide Synthase Domain

Positive Regulation of the MarR-type Regulator Slno and Improvement of Salinomycin Production by Streptomyces Albus by Multiple Transcriptional Regulation.

Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin

Effective Synthesis of C20‐epi‐Isothiocyanato‐Salinomycin and Its Thiourea Derivatives as Potential Anticancer Agents

Biosynthesis of a new skyllamycin analogue in Streptomyces nodosus: a cytochrome P450 forms an epoxide in the cinnamoyl chain

Biochemical analysis of the biosynthetic pathway of an anticancer tetracycline SF2575

Mechanism of Methyldehydrofosmidomycin Maturation: Use Olefination to Enable Chain Elongation

Formal Synthesis of (+)-Sinefungin by Way of Sequential Asymmetric Metal Catalysis